{"altmetric_id":3438996,"counts":{"readers":{"mendeley":3,"citeulike":0,"connotea":0},"total":{"posts_count":1},"wikipedia":{"unique_users_count":1,"unique_users":["en:11265221"],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa4eb3cf058f61000284e","authors":["Stephen M. Sorensen","Teresa M. Humphreys","Michael G. Palfreyman"],"doi":"10.1016\/0014-2999(89)90402-0","endpage":"118","first_seen_on":"2015-02-09T10:56:00+00:00","issns":["00142999"],"issue":"1","journal":"European Journal of Pharmacology","last_mentioned_on":1474736366,"links":["http:\/\/dx.doi.org\/10.1016\/0014-2999(89)90402-0"],"pubdate":"1989-04-01T00:00:00+00:00","scopus_subjects":["Life Sciences","Pharmacology, Toxicology and Pharmaceutics"],"startpage":"115","title":"Effect of acute and chronic MDL 73,147EF, a 5-HT3 receptor antagonist, on A9 and A10 dopamine neurons","type":"article","volume":"163","mendeley_url":"http:\/\/www.mendeley.com\/research\/effect-acute-chronic-mdl-73147ef-5ht3-receptor-antagonist-a9-a10-dopamine-neurons"},"altmetric_score":{"score":3,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3},"context_for_score":{"all":{"total_number_of_other_articles":8425604,"mean":7.0878923279354,"rank":2164568,"this_scored_higher_than_pct":60,"this_scored_higher_than":5111295,"rank_type":"exact","sample_size":8425604,"percentile":60},"similar_age_3m":{"total_number_of_other_articles":244316,"mean":8.4010312424534,"rank":70847,"this_scored_higher_than_pct":68,"this_scored_higher_than":167520,"rank_type":"exact","sample_size":244316,"percentile":68},"this_journal":{"total_number_of_other_articles":2552,"mean":2.8785637005096,"rank":345,"this_scored_higher_than_pct":47,"this_scored_higher_than":1216,"rank_type":"exact","sample_size":2552,"percentile":47},"similar_age_this_journal_3m":{"total_number_of_other_articles":48,"mean":1.6755319148936,"rank":7,"this_scored_higher_than_pct":83,"this_scored_higher_than":40,"rank_type":"exact","sample_size":48,"percentile":83}}},"demographics":{"users":{"mendeley":{"by_status":{"Researcher":2,"Student  > Postgraduate":1},"by_discipline":{"Medicine and Dentistry":1,"Neuroscience":1,"Chemistry":1}}}},"posts":{"wikipedia":[{"title":"5-HT3 antagonist","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=131429250#altmetric_citation_8","license":"public","citation_ids":[3438996,3438999],"posted_on":"2016-09-24T16:59:26+00:00","summary":"The 5-HT3 antagonists, informally known as \"setrons\", is a class of drugs that act as receptor antagonists at the 5-HT3 receptor, a subtype of serotonin receptor found in terminals of the vagus nerve and in certain areas of the brain.","page_url":"http:\/\/en.wikipedia.org\/?curid=11265221","wiki_lang":"en","author":{"name":"Doc James","url":"http:\/\/en.wikipedia.org\/wiki\/User:Doc James"}}]}}